Skip to main content

MARTINGALE ASSET MANAGEMENT L P

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 936944 BOSTON, MA

Position in SUPN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$3,491,556
+$595,637 QoQ
Shares Held
67,548
+15.9% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 63.58145318884348.ToString("F0")% Shared 0.ToString("F0")% None 36.41854681115651.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARTINGALE ASSET MANAGEMENT L P holds $47,192,066 across 16 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (7.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 SUPN
Supernus Pharmaceuticals, Inc.
This page
67,548 $3,491,556

All Filings in SUPN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,491,556 67,548
2025-12-31 $2,895,919 58,268
2025-09-30 $2,865,152 59,953
2025-06-30 $2,042,275 64,793
2025-03-31 $1,873,267 57,199
2024-12-31 $1,612,446 44,592
2024-09-30 $1,178,478 37,796
2024-06-30 $966,638 36,136
2024-03-31 $1,232,598 36,136
2023-12-31 $1,045,775 36,136
2023-09-30 $1,327,109 48,136
2023-06-30 $1,446,968 48,136
2023-03-31 $1,675,094 46,235
2022-12-31 $1,642,068 46,035
2022-09-30 $1,650,796 48,768
2022-06-30 $1,300,474 44,968
2022-03-31 $1,357,989 42,017
2021-12-31 $1,334,711 45,772
2021-09-30 $237,389 8,901
2021-03-31 $581,745 22,221
2020-12-31 $1,065,475 42,348
2020-09-30 $1,197,216 57,448
2020-06-30 $776,933 32,713